Concepedia

Margaret Wasilewski

MW

Statistics

Publications

8

Citations

536

H-Index

8

Active since

1996

Affiliations

Takeda (United States)(Current)

University Children's Hospital Tübingen

Rigshospitalet

Eli Lilly (United States)

Osaka University Hospital

Margaret Wasilewski is an author at Takeda (United States) specializing in pharmacology, medicine, and metachromatic leukodystrophy.

Publications per year

1996–2020

8

Publications

8

Daptomycin: a novel agent for Gram-positive infections

Francis P. Tally, Michael L. Zeckel, Margaret Wasilewski et al. · Expert Opinion on Investigational Drugs · 1999 · 206 citations

, , +17

Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo

Margaret Wasilewski, K. C. Lim, Jennifer L. Phillips et al. · Molecular and Biochemical Parasitology · 1996 · 125 citations

, , +17

Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial

Christine í Dali, Caroline Sevin, Ingeborg Krägeloh‐Mann et al. · Molecular Genetics and Metabolism · 2020 · 72 citations · Full text

, , +11

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

Lala M. Dunbar, Joe Milata, Ty McClure et al. · Antimicrobial Agents and Chemotherapy · 2011 · 64 citations

, , +17

Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study

Christine í Dali, Samuel Groeschel, Mihai Moldovan et al. · Annals of Clinical and Translational Neurology · 2020 · 27 citations · Full text

, , +17

1–5 of 8